Paul Kohlhaas & Tyler Golato: VitaDAO – The Collective Funding Longevity Research
Media Type |
audio
Categories Via RSS |
Business
Entrepreneurship
Investing
Technology
Publication Date |
Aug 04, 2021
Episode Duration |
01:27:50

VitaDAO is a decentralized collective funding early stage longevity research. Their mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.

We were joined by Tyler Golato and Paul Kohlhaas, co-founders of Molecule and initiators of VitaDAO to talk about how drug discovery and approval currently works, what the status of longevity research is, what role IP plays -- and how all of this could change in the future with DAOs like VitaDAO.

Topics covered in this episode:

  • Paul and Tyler's backgrounds and how they came to work on VitaDAO
  • Longevity - thinking of aging as a disease
  • Where is the research at today?
  • How longevity research currently takes place in the pharmaceutical industry
  • How VitaDAO is alleviating patency issues
  • The first funded project with the Knudsen lab in Copenhagen - Molecule
  • How DAOs make the decisions

Episode links:

Sponsors:

This episode is hosted by Friederike Ernst & Meher Roy. Show notes and listening options: epicenter.tv/403

We were joined by Tyler Golato and Paul Kohlhaas, co-founders of Molecule and initiators of VitaDAO to talk about how drug discovery and approval currently works, what the status of longevity research is, what role IP plays -- and how all of this could change in the future with DAOs like VitaDAO.

VitaDAO is a decentralized collective funding early stage longevity research. Their mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.

We were joined by Tyler Golato and Paul Kohlhaas, co-founders of Molecule and initiators of VitaDAO to talk about how drug discovery and approval currently works, what the status of longevity research is, what role IP plays -- and how all of this could change in the future with DAOs like VitaDAO.

Topics covered in this episode:

  • Paul and Tyler's backgrounds and how they came to work on VitaDAO
  • Longevity - thinking of aging as a disease
  • Where is the research at today?
  • How longevity research currently takes place in the pharmaceutical industry
  • How VitaDAO is alleviating patency issues
  • The first funded project with the Knudsen lab in Copenhagen - Molecule
  • How DAOs make the decisions

Episode links:

Sponsors:

This episode is hosted by Friederike Ernst & Meher Roy. Show notes and listening options: epicenter.tv/403

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review